Filing Details

Accession Number:
0001567619-19-006066
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-04 18:39:36
Reporting Period:
2019-03-04
Accepted Time:
2019-03-04 18:39:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380187 Daniel Abdun-Nabi 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-03-04 14,565 $58.11 142,617 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,936 Indirect By Son
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
  2. The price reported is the weighted average price. These shares were sold in multiple transactions at prices ranging from $56.74 to $59.66, inclusive.
  3. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.